Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients.

Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients. Neurosurgery. 2022 Dec 01; 91(6):872-882.

View in: PubMed

subject areas

Brain Neoplasms
Humans
Melanoma
Proto-Oncogene Proteins B-raf
Radiation Injuries
Radiosurgery
Retrospective Studies

authors with profiles

Timothy Dean Malouff